Preethi Sundaram Implements A Sell Strategy: Offloads $103K In Catalyst Pharmaceuticals Stock

benzinga.com/insights/news/25/06/45928452/preethi-sundaram-implements-a-sell-strategy-offloads-103k-in-catalyst-pharmaceuticals-stock

Revealing a significant insider sell on June 12, Preethi Sundaram, Chief Strategy Officer at Catalyst Pharmaceuticals CPRX, as per the latest SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Sundaram sold 3,924 shares of…

This story appeared on benzinga.com, 2025-06-13 15:01:45.
The Entire Business World on a Single Page. Free to Use →